<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
<meta http-equiv="Content-Type" content=
"text/html; charset=utf-8" /><!-- AppResources meta begin -->

<script type="text/javascript">
//<![CDATA[
var ncbi_startTime = new Date();
//]]>
</script><!-- AppResources meta end -->
<!-- TemplateResources meta begin -->
<meta name="paf_template" content="" />
<!-- TemplateResources meta end -->
<!-- Logger begin -->
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_pdid" content="article" />
<meta name="ncbi_acc" content="" />
<meta name="ncbi_domain" content="brjclinpharm" />
<meta name="ncbi_report" content="record" />
<meta name="ncbi_type" content="fulltext" />
<meta name="ncbi_objectid" content="" />
<meta name="ncbi_pcid" content="/articles/PMC2015054/" />
<meta name="ncbi_app" content="pmc" /><!-- Logger end -->
<title>Single- and multiple-dose pharmacokinetics of ziprasidone in
healthy young and elderly volunteers</title>
<!-- AppResources external_resources begin -->
<link rel="stylesheet" href="/core/jig/1.14.4/css/jig.min.css" />
<script type="text/javascript" src=
"/core/jig/1.14.4/js/jig.min.js">
</script><!-- AppResources external_resources end -->
<!-- Page meta begin -->
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" />
<link rel="canonical" href="/pmc/articles/PMC2015054/" />
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" />
<meta name="citation_journal_title" content=
"British Journal of Clinical Pharmacology" />
<meta name="citation_title" content=
"Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers" />
<meta name="citation_authors" content=
"K D Wilner, T G Tensfeldt, B Baris, T A Smolarek, R Z Turncliff, W A Colburn, R A Hansen" />
<meta name="citation_date" content="January 2000" />
<meta name="citation_issue" content="Suppl 1" />
<meta name="citation_volume" content="49" />
<meta name="citation_firstpage" content="15S" />
<meta name="citation_doi" content=
"10.1046/j.1365-2125.2000.00148.x" />
<meta name="citation_abstract_html_url" content=
"/pmc/articles/PMC2015054/?report=abstract" />
<meta name="citation_pmid" content="10771449" />
<meta name="DC.Title" content=
"Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers" />
<meta name="DC.Type" content="Text" />
<meta name="DC.Publisher" content="Wiley-Blackwell" />
<meta name="DC.Contributor" content="K D Wilner" />
<meta name="DC.Contributor" content="T G Tensfeldt" />
<meta name="DC.Contributor" content="B Baris" />
<meta name="DC.Contributor" content="T A Smolarek" />
<meta name="DC.Contributor" content="R Z Turncliff" />
<meta name="DC.Contributor" content="W A Colburn" />
<meta name="DC.Contributor" content="R A Hansen" />
<meta name="DC.Date" content="2000 Jan" />
<meta name="DC.Identifier" content=
"10.1046/j.1365-2125.2000.00148.x" />
<meta name="DC.Language" content="en" />
<meta property="og:title" content=
"Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers" />
<meta property="og:type" content="article" />
<meta property="og:description" content=
"To compare the pharmacokinetics of ziprasidone in healthy young (18–45 years) men and women, and healthy elderly (≥ 65 years) men and women.Eight young men, 11 young women, 8 elderly men and 8 elderly women were given oral ziprasidone ..." />
<meta property="og:url" content=
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2015054/" />
<meta property="og:site_name" content="PubMed Central (PMC)" />
<meta property="og:image" content=
"http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:site" content="@ncbi" />
<link rel="stylesheet" href="/corehtml/pmc/css/3.4/pmc.min.css"
type="text/css" />
<link rel="stylesheet" href=
"/corehtml/pmc/css/3.4/pmc_extras_prnt.min.css" type="text/css"
media="print" />
<script type="text/javascript" src=
"/corehtml/pmc/js/common.min.js">
//<![CDATA[
//
//]]>
</script>
<script type="text/javascript" src=
"/corehtml/pmc/js/NcbiTagServer.min.js">
//<![CDATA[
//
//]]>
</script>
<meta name="citationexporter" content=
"backend:'/pmc/utils/ctxp/'" />
<script type="text/javascript" src=
"/corehtml/pmc/ctxp/jquery.citationexporter.js">
//<![CDATA[
//
//]]>
</script>
<link rel="stylesheet" href=
"/corehtml/pmc/ctxp/citationexporter.css" type="text/css" />
<script type="text/javascript" src=
"/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js">
</script>
<script type="text/javascript" src=
"/corehtml/pmc/js/large-obj-scrollbars.min.js">
</script>
<script type="text/javascript">
//<![CDATA[
window.name="mainwindow";
//]]>
</script>
<style type="text/css">
/*<![CDATA[*/
.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brjclinpharm.gif);background-size: auto, contain}
/*]]>*/
</style>

<style type="text/css">
/*<![CDATA[*/
.print-view{display:block}
/*]]>*/
</style>

<style type="text/css">
/*<![CDATA[*/
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
/*]]>*/
</style>
<link rel="alternate" type="application/epub+zip" href=
"/pmc/articles/PMC2015054/epub/" />
<link rel="alternate" type="application/pdf" href=
"/pmc/articles/PMC2015054/pdf/bcp0049-015S.pdf" />
<!-- Page meta end -->
<link rel="shortcut icon" href=
"//www.ncbi.nlm.nih.gov/favicon.ico" />
<meta name="ncbi_phid" content=
"8A1A2B6B6FE7D0E1000000000066D9DB" />
<link type="text/css" rel="stylesheet" href=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/css/3852956/3985586/3808861/3734262/3974050/3917732/251717/4048120/3846471/14534/45193/3988413/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4052581/9685/3549676/3609192/3609193/3609213/3395586/3855312.css" />
<link type="text/css" rel="stylesheet" href=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/css/3411343/3882866/3929378.css"
media="print" />
</head>
<body class="article">
<div class="grid">
<div class="col twelve_col nomargin shadow">
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
<div class="sysmessages"><noscript>
<p class="nojs"><strong>Warning:</strong> The NCBI web site
requires JavaScript to function. <a href=
"/guide/browsers/#enablejs" title="Learn how to enable JavaScript"
target="_blank">more...</a></p>
</noscript></div>
<!--/.sysmessage-->
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header">
<ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id=
"navcontent">
<li class=
"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt">
<a class="ui-ncbimenu-link-first" href="/" role="banner" title=
"NCBI Home" id="ncbihome" accesskey="1"><span class=
"offscreen_noflow">NCBI</span><img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/28977"
class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"#maincontent" title="Skip to the content" tabindex="0" accesskey=
"3">Skip to main content</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"#navcontent" title="Skip to the navigation" tabindex="0"
accesskey="4">Skip to navigation</a></li>
<li id="resource-menu" class=
"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset">
<a class=
"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown"
href=
"/static/header_footer_ajax/submenu/#resources">Resources</a></li>
<li id="all-howtos-menu" class=
"topmenu ui-helper-reset ui-ncbimenu-item-first"><a class=
"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown"
href="/static/header_footer_ajax/submenu/#howto">How To</a></li>
<li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href=
"/guide/browsers/#accesskeys" title="About My NCBI Accesskeys"
tabindex="0" accesskey="0">About NCBI Accesskeys</a></li>
</ul>
<div class="myncbi"><span id="myncbiusername" style=
"display:none"><a href="/account/settings/" id="mnu" title=
"Edit account settings"></a></span><a accesskey="2" href="/myncbi/"
id="myncbi" style="display:none">My NCBI</a><a href="/account/" id=
"sign_in">Sign in to NCBI</a><a href="/account/signout/" id=
"sign_out" style="display:none">Sign Out</a></div>
</div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a href="/pmc/" class=
"pmc_logo offscreen">PMC</a></h1>
<div class="NLMLogo"><a href="http://www.nlm.nih.gov/" title=
"US National Library of Medicine">US National Library of
Medicine</a><br />
<a href="http://www.nih.gov/" title=
"National Institutes of Health">National Institutes of
Health</a></div>
</div>
<div class="search">
<form method="get" action="/pmc/">
<div class="search_form"><label for="database" class=
"offscreen_noflow">Search database</label><select id="database">
<optgroup label="Recent">
<option value="pmc" selected="selected" class="last" data-ac_dict=
"pmc-search-autocomplete">PMC</option>
</optgroup>
<optgroup label="All">
<option value="gquery">All Databases</option>
<option value="assembly">Assembly</option>
<option value="bioproject">BioProject</option>
<option value="biosample">BioSample</option>
<option value="biosystems">BioSystems</option>
<option value="books">Books</option>
<option value="clinvar">ClinVar</option>
<option value="clone">Clone</option>
<option value="cdd">Conserved Domains</option>
<option value="gap">dbGaP</option>
<option value="dbvar">dbVar</option>
<option value="epigenomics">Epigenomics</option>
<option value="nucest">EST</option>
<option value="gene">Gene</option>
<option value="genome">Genome</option>
<option value="gds">GEO DataSets</option>
<option value="geoprofiles">GEO Profiles</option>
<option value="nucgss">GSS</option>
<option value="gtr">GTR</option>
<option value="homologene">HomoloGene</option>
<option value="medgen">MedGen</option>
<option value="mesh">MeSH</option>
<option value="ncbisearch">NCBI Web Site</option>
<option value="nlmcatalog">NLM Catalog</option>
<option value="nuccore">Nucleotide</option>
<option value="omim">OMIM</option>
<option value="pmc" data-ac_dict="pmc-search-autocomplete">
PMC</option>
<option value="popset">PopSet</option>
<option value="probe">Probe</option>
<option value="protein">Protein</option>
<option value="proteinclusters">Protein Clusters</option>
<option value="pcassay">PubChem BioAssay</option>
<option value="pccompound">PubChem Compound</option>
<option value="pcsubstance">PubChem Substance</option>
<option value="pubmed">PubMed</option>
<option value="pubmedhealth">PubMed Health</option>
<option value="snp">SNP</option>
<option value="sra">SRA</option>
<option value="structure">Structure</option>
<option value="taxonomy">Taxonomy</option>
<option value="toolkit">ToolKit</option>
<option value="toolkitall">ToolKitAll</option>
<option value="toolkitbook">ToolKitBook</option>
<option value="toolkitbookgh">ToolKitBookgh</option>
<option value="unigene">UniGene</option>
</optgroup>
</select>
<div class="nowrap"><label for="term" class="offscreen_noflow"
accesskey="/">Search term</label>
<div class="nowrap"><input type="text" name="term" id="term" title=
"Search PMC. Use up and down arrows to choose an item from the autocomplete."
value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config=
"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'"
autocomplete="off" data-sbconfig=
"ds:'no',pjs:'no',afs:'yes'" /></div>
<button id="search" type="submit" class="button_search nowrap" cmd=
"go">Search</button></div>
</div>
</form>
<ul class="searchlinks inline_list">
<li><a href="/pmc/limits/">Limits</a></li>
<li><a href="/pmc/advanced/">Advanced</a></li>
<li><a href="/pmc/journals/">Journal list</a></li>
<li class="help"><a target="_blank" href=
"/books/NBK3825/">Help</a></li>
</ul>
</div>
</div>
<!--<component id="Page" label="headcontent"/>--></div>
<div class="content"><!-- site messages -->
<div class="container">
<div id="maincontent" class="content eight_col col">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small">
<li class="journal-list"><a href="/pmc/journals/" class=
"navlink">Journal List</a></li>
<li class="archive-page"><a class="navlink" href=
"/pmc/journals/279/">Br J Clin Pharmacol</a></li>
<li class="issue-page"><a class="navlink" href=
"/pmc/issues/151586/">v.49(Suppl 1); 2000 Jan</a></li>
<li class="accid">PMC2015054</li>
</ul>
</div>
<!-- Journal banner -->
<div class="pmc-page-banner whole_rhythm">
<div><img src="/corehtml/pmc/pmcgifs/logo-brjclinpharm.gif" alt=
"Logo of brjclinpharm" usemap="#logo-imagemap" /><map id=
"logo-imagemap" name="logo-imagemap">
<area alt="Link to Publisher's site" title=
"Link to Publisher's site" shape="default" coords="0,0,499,74"
href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251"
target="pmc_ext" ref=
"reftype=publisher&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" />
</map></div>
</div>
<!--component id='MainPortlet' label='search-reference'/-->
<!-- Book content -->
<div class="">
<div class=
"hide-overflow article lit-style content pmc-wm slang-all page-box">
<!--main-content-->
<div class="jig-ncbiinpagenav" data-jigconfig=
"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'">
<div class="fm-sec half_rhythm no_top_margin">
<div class="fm-citation half_rhythm no_top_margin clearfix">
<div class="small">
<div class="inline_block eight_col va_top">
<div>
<div><span class="cit">Br J Clin Pharmacol. 2000 Jan; 49(Suppl 1):
15S–20S.</span></div>
<div><span class="doi">doi:&nbsp; <a href=
"http://dx.doi.org/10.1046%2Fj.1365-2125.2000.00148.x" target=
"pmc_ext" ref=
"reftype=other&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">
10.1046/j.1365-2125.2000.00148.x</a></span></div>
</div>
</div>
<div class=
"inline_block four_col va_top show-overflow align_right">
<div class="fm-citation-ids">
<div class="fm-citation-pmcid"><span class=
"fm-citation-ids-label">PMCID:</span> <span>PMC2015054</span></div>
</div>
</div>
</div>
</div>
<h1 class="content-title">Single- and multiple-dose
pharmacokinetics of ziprasidone in healthy young and elderly
volunteers</h1>
<div class="half_rhythm">
<div class="contrib-group fm-author"><a href=
"/pubmed/?term=Wilner%20KD%5Bauth%5D">K D Wilner</a>,<sup>1</sup>
<a href="/pubmed/?term=Tensfeldt%20TG%5Bauth%5D">T G
Tensfeldt</a>,<sup>1</sup> <a href=
"/pubmed/?term=Baris%20B%5Bauth%5D">B Baris</a>,<sup>1</sup>
<a href="/pubmed/?term=Smolarek%20TA%5Bauth%5D">T A
Smolarek</a>,<sup>2</sup> <a href=
"/pubmed/?term=Turncliff%20RZ%5Bauth%5D">R Z
Turncliff</a>,<sup>2</sup> <a href=
"/pubmed/?term=Colburn%20WA%5Bauth%5D">W A Colburn</a>,<sup>3</sup>
and <a href="/pubmed/?term=Hansen%20RA%5Bauth%5D">R A
Hansen</a><sup>1</sup></div>
</div>
<div class="fm-panel small half_rhythm">
<div class="fm-authors-info fm-panel hide half_rhythm" id=
"id791011_ai" style="display:none">
<div class="fm-affl" lang="en"><sup>1</sup>Departments of Clinical
Research, Pfizer Central Research, Groton, CT 06340, USA</div>
<div class="fm-affl" lang="en"><sup>2</sup>Drug Metabolism, Pfizer
Central Research, Groton, CT 06340, USA</div>
<div class="fm-affl" lang="en"><sup>3</sup>Harris Laboratories
Inc., Phoenix, AZ, USA</div>
<div id="cor1"><em>Correspondence:</em> Dr K. D. Wilner, Department
of Clinical Pharmacology, Pfizer Central Research, Groton, CT
06340, USA.</div>
</div>
<div class="togglers"><a href="#" class="pmctoggle" rid=
"id791011_ai">Author information <span>►</span></a> <a href="#"
class="pmctoggle" rid="id791011_cpl">Copyright and License
information <span>►</span></a></div>
<div class="fm-article-notes fm-panel half_rhythm"></div>
<div class="fm-cpl-info fm-panel hide half_rhythm" id=
"id791011_cpl" style="display:none">
<div class="fm-copyright half_rhythm"><a href=
"/pmc/about/copyright.html">Copyright</a> © 2000 Blackwell Science
Ltd</div>
</div>
</div>
<div class="links-box fm-panel whole_rhythm">
<div class="small">
<div>This article has been <a href=
"/pmc/articles/PMC2015054/citedby/">cited by</a> other articles in
PMC.</div>
</div>
</div>
</div>
<div class="sec"></div>
<div id="__abstractid175508" lang="en" class="tsec sec">
<h2 class="head no_bottom_margin" id="__abstractid175508title">
Abstract</h2>
<!--article-meta-->
<div>
<div id="__sec1" class="sec sec-first">
<h3>Aims</h3>
<p id="__p1" class="p p-first-last">To compare the pharmacokinetics
of ziprasidone in healthy young (18–45 years) men and women, and
healthy elderly (≥ 65 years) men and women.</p>
</div>
<div id="__sec2" class="sec">
<h3>Methods</h3>
<p id="__p2" class="p p-first-last">Eight young men, 11 young
women, 8 elderly men and 8 elderly women were given oral
ziprasidone 40 mg day<sup>−1</sup>, in two evenly divided daily
doses, for 7 days, followed by a single 20 mg dose on day 8. Serum
samples were collected immediately before the morning dose on days
1–8, for up to 12 h after dosing on day 1 and for up to 96 h after
dosing on day 8. The resulting data were used to derive
pharmacokinetic parameters of ziprasidone in each age and gender
group.</p>
</div>
<div id="__sec3" class="sec">
<h3>Results</h3>
<p id="__p3" class="p p-first-last">Steady-state serum
concentrations of ziprasidone were achieved within 2–3 days. The
steady-state pharmacokinetics of ziprasidone, determined 8 days
after the initiation of treatment, were similar in the young men,
elderly men and young women. Assessment of gender effects by
analysis of variance revealed statistically significant differences
in <em>C</em><sub>max</sub> (85 <em>vs</em> 69 ng ml<sup>−1</sup>)
and <em>t</em><sub>max</sub> (3.19 <em>vs</em> 4.81 h) but no
differences in AUC(0,12 h) or λ<sub>z</sub>. Assessment of age
effects by analysis of variance revealed statistically significant
differences in AUC(0,12 h) (560 <em>vs</em> 465 ng
ml<sup>−1</sup>h), <em>C</em><sub>max</sub> (85 <em>vs</em> 69 ng
ml<sup>−1</sup>) and λ<sub>z</sub> (0.126 <em>vs</em> 0.197 l
h<sup>−1</sup>) but no difference in <em>t</em><sub>max</sub>.
Assessment of age and gender effects by analysis of covariance,
with body weight as the covariate, did not reveal any significant
differences. The mean <em>t</em><sub>½,z</sub> in the young men,
young women, elderly men and elderly women were 3.1, 4.1, 5.7 and
5.3 h, respectively. Standard deviations of the means for the
pharmacokinetic parameters for the elderly women tended to be
large.</p>
</div>
<div id="__sec4" class="sec sec-last">
<h3>Conclusions</h3>
<p id="__p4" class="p p-first-last">The influence of age and gender
on the pharmacokinetics of ziprasidone is not clinically
significant.</p>
</div>
</div>
<div class="sec"><strong class="kwd-title">Keywords:</strong>
<span class="kwd-text">age, gender, pharmacokinetics,
schizoaffective, schizophrenia, ziprasidone</span></div>
</div>
<div id="__sec5" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec5title">
Introduction</h2>
<p id="__p5" class="p p-first">A previous study in healthy men has
shown that ziprasidone has a pharmacokinetic profile which is
characterized by rapid attainment of steady state and
dose-proportional <em>C</em><sub>max</sub> and AUC(0,12 h)
[<a href="#b1" rid="b1" class=
" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012640">1</a>]. Ziprasidone appears to be extensively
metabolized and less than 1% is excreted unchanged in the urine or
faeces. The major metabolites of ziprasidone are inactive [<a href=
"#b2" rid="b2" class=" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012639">2</a>].</p>
<p id="__p6" class="p p-last">Studies to characterize the
pharmacokinetics of ziprasidone that have been undertaken to date
have involved mainly young men. However, the target population for
ziprasidone in clinical practice will include men and women of all
ages. Here we report the findings of a study designed to evaluate
the effects of age and gender on the pharmacokinetics of
ziprasidone.</p>
</div>
<div id="__sec6" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec6title">Methods</h2>
<div id="__sec7" class="sec sec-first">
<h3>Subjects</h3>
<p id="__p7" class="p p-first">The study subjects were healthy
young (18–45 years) and elderly (≥ 65 years) men and women. All
subjects had a body weight ≤ 91 kg. The young subjects were within
10% of the ideal weight for age and height [<a href="#b3" rid="b3"
class=" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012638">3</a>] and the elderly subjects were within 20%
of their ideal weight. The women had been surgically sterilized,
were at least 2 years postmenopausal or had been practising
successful contraception for at least 3 months. Pregnant or
lactating women were excluded from the study.</p>
<p id="__p8" class="p p-last">The study protocol was approved by an
independent institutional review board. All subjects provided
written informed consent.</p>
</div>
<div id="__sec8" class="sec">
<h3>Study design</h3>
<p id="__p9" class="p p-first">This was an open-label,
multiple-dose study designed to evaluate the pharmacokinetics of
ziprasidone at steady-state in healthy young men, young women,
elderly men and elderly women.</p>
<p id="__p10" class="p p-last">Ziprasidone was administered orally
at a dose of 40 mg day<sup>−1</sup>, in two evenly divided daily
doses for 7 days, followed by a single dose on the morning of day
8. The morning dose of ziprasidone was given with 50 ml water
immediately after a standard breakfast which was eaten over a 20
min period. The evening dose was given with 50 ml water immediately
after a standard dinner which was also eaten over a 20 min period.
The interval between the morning and evening dose was approximately
12 h.</p>
</div>
<div id="__sec9" class="sec">
<h3>Pharmacokinetic sampling</h3>
<p id="__p11" class="p p-first">Blood samples for the determination
of single-dose pharmacokinetic parameters were collected before
dosing and for up to 12 h after the morning dose of ziprasidone on
day 1. Samples for the determination of steady-state
pharmacokinetic parameters were obtained immediately before dosing
and up to 96 h after the morning dose of ziprasidone on day 8.
Additional samples for the determination of trough serum levels of
ziprasidone were collected immediately before the morning dose on
days 2, 3, 4, 5, 6 and 7.</p>
<p id="__p12" class="p p-last">Plasma protein-binding (<em>Fb</em>)
determinations were undertaken in samples taken immediately before
administration of the last dose of ziprasidone on day 8.</p>
</div>
<div id="__sec10" class="sec">
<h3>Pharmacokinetic analysis</h3>
<p id="__p13" class="p p-first">Serum concentrations of ziprasidone
were determined using high-performance liquid chromatography
(h.p.l.c.) involving solid-phase extraction and u.v. detection. The
assay had a dynamic range of 1.0–250.0 ng ml<sup>−1</sup>[<a href=
"#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012637">4</a>]. Ziprasidone concentrations below the
lower limit of quantification were assigned a value of 0 ng
ml<sup>−1</sup> in pharmacokinetic calculations.</p>
<p id="__p14">The maximum observed serum concentration of
ziprasidone (<em>C</em><sub>max</sub>) and the earliest time at
which <em>C</em><sub>max</sub> occurred (<em>t</em><sub>max</sub>)
were estimated directly from the experimental data. The area under
the serum concentration-time curve to the 12th hour after dosing
(AUC(0, 12 h)) was estimated by linear trapezoidal approximation,
and the accumulation ratio was calculated as the AUC(0,12 h) on day
8 divided by AUC(0,12 h) on day 1.</p>
<p id="__p15" class="p p-last">The elimination rate constant
(λ<sub>z</sub>), was derived from least-squares regression analysis
of the serum concentration-time data obtained during the terminal
log-linear phase. The half-life (<em>t</em><sub>½,z</sub>) was
calculated as ln 2/λ<sub>z</sub> and mean <em>t</em><sub>½,z</sub>
was calculated as ln 2/mean λ<sub>z</sub>.</p>
</div>
<div id="__sec11" class="sec sec-last">
<h3>Statistical analysis</h3>
<p id="__p16" class="p p-first">It was estimated that a sample size
of eight completing subjects per group (i.e. young men, young
women, elderly men and elderly women) would provide 80% power to
detect at least a 75% between-group difference in the AUC on day 8,
at a significance level of 5%.</p>
<p id="__p17">Analysis of AUC(0,12 h) and <em>C</em><sub>max</sub>
was undertaken on natural log-transformed data; other variables
were unadjusted. Each pharmacokinetic parameter was analysed as a
dependent variable in a two-way analysis of variance model that
used age, gender and the age-by-gender interaction as
classification variables (PROC GLM of SAS®).</p>
<p id="__p18" class="p p-last">Differences in AUC(0,12 h) and
<em>C</em><sub>max</sub> were also tested by means of a two-way
analysis of covariance model in which age, gender and the
age-by-gender interaction were classification variables and body
weight was a continuous covariate. Student’s <em>t</em>-tests with
95% confidence limits were used to examine pair-wise differences
between the groups. Values of <em>P</em>&lt; 0.05 were considered
to be statistically significant.</p>
</div>
</div>
<div id="__sec12" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec12title">Results</h2>
<div id="__sec13" class="sec sec-first">
<h3>Subjects</h3>
<p id="__p19" class="p p-first">Thirty-five subjects participated
in the study: eight subjects each were young men, elderly men and
elderly women, and 11 were young women.</p>
<p id="__p20">The demographic characteristics of the subject groups
are summarized in <a href="/pmc/articles/PMC2015054/table/tbl1/"
target="true" class="fig-table-link table figpopup" rid-figpopup=
"tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>.
The majority of the subjects were Caucasian. There was one Black
young man and one Black and one Hispanic young woman.</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl1"><a href="/pmc/articles/PMC2015054/table/tbl1/" target=
"table" rid-ob="ob-tbl1" rid-figpopup="tbl1" class=
"table img_link icnblk_img figpopup"><img alt="Table 1" title=
"Table 1" class="small-thumb" src=
"/pmc/articles/PMC2015054/table/tbl1/?report=thumb" src-large=
"/pmc/articles/PMC2015054/table/tbl1/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/table/tbl1/" target="table" rid-figpopup=
"tbl1" rid-ob="ob-tbl1">Table 1</a></div>
<!--caption a4-->
<div><span>Baseline demographic characteristics</span></div>
</div>
</div>
<p id="__p22" class="p p-last">Three of the young women withdrew
from the study within the first 3 days of treatment because of
treatment-related adverse events (mild lack of energy; mild nausea
and dizziness, and a road traffic accident). These subjects were
excluded in the analysis of pharmacokinetic data.</p>
</div>
<div id="__sec14" class="sec">
<h3>Single-dose pharmacokinetics</h3>
<p id="__p23" class="p p-first">Serum ziprasidone
concentration-time curves generated following the administration of
a single 20 mg dose of ziprasidone are shown in <a href=
"/pmc/articles/PMC2015054/figure/fig01/" target="figure" class=
"fig-table-link fig figpopup" rid-figpopup="fig01" rid-ob=
"ob-fig01" co-legend-rid="lgnd_fig01"><span>Figure 1</span></a>.
The mean AUC(0,12 h) on day 1 was approximately 11% greater in the
elderly than in the young subjects (382 ng ml<sup>−1</sup>h
<em>vs</em> 344 ng ml<sup>−1</sup> h), and mean
<em>C</em><sub>max</sub> was approximately 7% greater in the
elderly than in the young subjects (60 ng
ml<sup>−1</sup><em>vs</em> 56 ng ml<sup>−1</sup>; <a href=
"/pmc/articles/PMC2015054/table/tbl2/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob=
"ob-tbl2" co-legend-rid=""><span>Table 2</span></a>). Exposure to
ziprasidone in the elderly women, measured by the AUC(0,12 h), was
approximately 14% greater than in the elderly men (408 ng
ml<sup>−1</sup> h <em>vs</em> 358 ng ml<sup>−1</sup> h), and the
<em>C</em><sub>max</sub> in the elderly women was approximately 22%
greater than in the elderly men (66 ng ml<sup>−1</sup><em>vs</em>
54 ng ml<sup>−1</sup>). The mean <em>t</em><sub>max</sub> after the
first dose of ziprasidone was between 4 and 5 h in all subject
groups.</p>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig01"
co-legend-rid="lgnd_fig01"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015054/figure/fig01/" target="figure"
rid-figpopup="fig01" rid-ob="ob-fig01"><img src=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f1.gif" class=
"small-thumb" alt="Figure 1" title="Figure 1" src-large=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f1.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig01">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/figure/fig01/" target="figure"
rid-figpopup="fig01" rid-ob="ob-fig01">Figure 1</a></div>
<!--caption a4-->
<div><span>Mean ziprasidone serum concentrations following
administration of a single ziprasidone 20 mg dose to healthy young
men (–––), young women (-·-·), elderly men (----) and elderly women
(…..).</span></div>
</div>
</div>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl2"><a href="/pmc/articles/PMC2015054/table/tbl2/" target=
"table" rid-ob="ob-tbl2" rid-figpopup="tbl2" class=
"table img_link icnblk_img figpopup"><img alt="Table 2" title=
"Table 2" class="small-thumb" src=
"/pmc/articles/PMC2015054/table/tbl2/?report=thumb" src-large=
"/pmc/articles/PMC2015054/table/tbl2/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/table/tbl2/" target="table" rid-figpopup=
"tbl2" rid-ob="ob-tbl2">Table 2</a></div>
<!--caption a4-->
<div><span>Summary of pharmacokinetic parameters (mean ± s.d.)
following single 20 mg dose of ziprasidone</span></div>
</div>
</div>
</div>
<div id="__sec15" class="sec sec-last">
<h3>Steady-state pharmacokinetics</h3>
<p id="__p28" class="p p-first">Serum ziprasidone
concentration–time curves on day 8 are shown in <a href=
"/pmc/articles/PMC2015054/figure/fig02/" target="figure" class=
"fig-table-link fig figpopup" rid-figpopup="fig02" rid-ob=
"ob-fig02" co-legend-rid="lgnd_fig02"><span>Figure 2</span></a>.
Visual inspection of trough serum ziprasidone concentrations
suggested that steady state was attained within 2–3 days of the
start of dosing. The mean accumulation ratios, calculated as the
ratio of AUC(0,12 h), day 8/AUC(0,12 h), day 1, were similar in all
four groups. These were 1.27, 1.46, 1.43 and 1.54 in the young men,
young women, elderly men and elderly women, respectively. Among the
young and elderly of both genders the mean accumulation ratios were
1.36 and 1.48, respectively.</p>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig02"
co-legend-rid="lgnd_fig02"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015054/figure/fig02/" target="figure"
rid-figpopup="fig02" rid-ob="ob-fig02"><img src=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f2.gif" class=
"small-thumb" alt="Figure 2" title="Figure 2" src-large=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f2.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig02">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/figure/fig02/" target="figure"
rid-figpopup="fig02" rid-ob="ob-fig02">Figure 2</a></div>
<!--caption a4-->
<div><span>Mean ziprasidone serum concentrations on day 8 following
administration of ziprasidone 20 mg twice daily for 8 days to
healthy young men (–––), young women (-·-·), elderly men (----) and
elderly women (…..).</span> <strong>...</strong></div>
</div>
</div>
<p id="__p30">Based on steady-state AUC(0,12 h),
<em>C</em><sub>max</sub>, <em>t</em><sub>max</sub> and
λ<sub>z</sub> values, the pharmacokinetics of ziprasidone in young
men were similar to those in young women (<a href=
"/pmc/articles/PMC2015054/table/tbl3/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob=
"ob-tbl3" co-legend-rid=""><span>Table 3</span></a>). In addition,
overall exposure based on AUC(0,12 h) and <em>C</em><sub>max</sub>
was similar among elderly men, young men and young women. However,
exposure in elderly women was greater than that in elderly men (23%
for AUC(0,12 h) and 44% for <em>C</em><sub>max</sub>). Normalizing
AUC(0,12 h) and <em>C</em><sub>max</sub> values for body weight (70
kg) did not account for this difference in exposure (<a href=
"/pmc/articles/PMC2015054/table/tbl3/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob=
"ob-tbl3" co-legend-rid=""><span>Table 3</span></a>).</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl3"><a href="/pmc/articles/PMC2015054/table/tbl3/" target=
"table" rid-ob="ob-tbl3" rid-figpopup="tbl3" class=
"table img_link icnblk_img figpopup"><img alt="Table 3" title=
"Table 3" class="small-thumb" src=
"/pmc/articles/PMC2015054/table/tbl3/?report=thumb" src-large=
"/pmc/articles/PMC2015054/table/tbl3/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/table/tbl3/" target="table" rid-figpopup=
"tbl3" rid-ob="ob-tbl3">Table 3</a></div>
<!--caption a4-->
<div><span>Summary of pharmacokinetic parameters (mean±s.d.) at
steady state following administration of ziprasidone, 40 mg
day<sup>−1</sup> for 8 days.</span></div>
</div>
</div>
<p id="__p35">The unusual pharmacokinetics observed in the elderly
women were principally due to two elderly women who had very high
AUC(0,12 h) (867 and 881 ngml<sup>−1</sup> h) and
<em>C</em><sub>max</sub> values (182 and 166 ng ml<sup>−1</sup>).
These individuals can be identified in <a href=
"/pmc/articles/PMC2015054/figure/fig03/" target="figure" class=
"fig-table-link fig figpopup" rid-figpopup="fig03" rid-ob=
"ob-fig03" co-legend-rid="lgnd_fig03"><span>Figures 3</span></a>
and <a href="/pmc/articles/PMC2015054/figure/fig04/" target=
"figure" class="fig-table-link fig figpopup" rid-figpopup="fig04"
rid-ob="ob-fig04" co-legend-rid="lgnd_fig04"><span style=
"position: relative;text-decoration:none;">​<span class=
"figpopup-sensitive-area" style=
"left: -1.5em;">and4</span></span><span>4</span></a>.</p>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig03"
co-legend-rid="lgnd_fig03"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015054/figure/fig03/" target="figure"
rid-figpopup="fig03" rid-ob="ob-fig03"><img src=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f3.gif" class=
"small-thumb" alt="Figure 3" title="Figure 3" src-large=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f3.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig03">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/figure/fig03/" target="figure"
rid-figpopup="fig03" rid-ob="ob-fig03">Figure 3</a></div>
<!--caption a4-->
<div><span>Individual AUC(0,12 h) following administration of
ziprasidone 20 mg twice daily for 8 days to healthy young men (♦),
young women (◊), elderly men (▪) and elderly women (□). Group means
are denoted by horizontal lines.</span></div>
</div>
</div>
<!--fig ft0--><!--fig mode=article f1-->
<div class="fig iconblock ten_col whole_rhythm clearfix" id="fig04"
co-legend-rid="lgnd_fig04"><a class="icnblk_img figpopup" href=
"/pmc/articles/PMC2015054/figure/fig04/" target="figure"
rid-figpopup="fig04" rid-ob="ob-fig04"><img src=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f4.gif" class=
"small-thumb" alt="Figure 4" title="Figure 4" src-large=
"/pmc/articles/PMC2015054/bin/bcp0049-015S-f4.jpg" /></a>
<div class="icnblk_cntnt" id="lgnd_fig04">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/figure/fig04/" target="figure"
rid-figpopup="fig04" rid-ob="ob-fig04">Figure 4</a></div>
<!--caption a4-->
<div><span>Individual <em>C</em><sub>max</sub> following
administration of ziprasidone 20 mg twice daily for 8 days to
healthy young men (♦), young women (◊), elderly men (▪) and elderly
women (□). Group means are denoted by horizontal
lines.</span></div>
</div>
</div>
<p id="__p38">In general, steady-state <em>t</em><sub>½,z</sub>
values were broadly similar in young men and young women (3.1 h
<em>vs</em> 4.1 h; <a href="/pmc/articles/PMC2015054/table/tbl3/"
target="true" class="fig-table-link table figpopup" rid-figpopup=
"tbl3" rid-ob="ob-tbl3" co-legend-rid=""><span>Table 3</span></a>),
and in elderly men and elderly women (5.7 h <em>vs</em> 5.3 h;
<a href="/pmc/articles/PMC2015054/table/tbl3/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob=
"ob-tbl3" co-legend-rid=""><span>Table 3</span></a>). The mean
<em>t</em><sub>½,z</sub> in the elderly subjects (both genders) was
2 h longer than in the young subjects (both genders) (5.5 h
<em>vs</em> 3.5 h).</p>
<p id="__p39">The mean per cent plasma protein binding
(<em>Fb</em>) was almost identical among the four groups (99.8% to
99.9%; <a href="/pmc/articles/PMC2015054/table/tbl3/" target="true"
class="fig-table-link table figpopup" rid-figpopup="tbl3" rid-ob=
"ob-tbl3" co-legend-rid=""><span>Table 3</span></a>).</p>
<p id="__p40">Comparisons of AUC(0,12 h) and
<em>C</em><sub>max</sub> between the young and elderly subject
groups by two-way analysis of variance showed small but
statistically significantly greater ziprasidone exposure in elderly
subjects (both genders) of between 20 and 23% (<a href=
"/pmc/articles/PMC2015054/table/tbl4/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl4" rid-ob=
"ob-tbl4" co-legend-rid=""><span>Table 4</span></a>; <em>P</em>&lt;
0.05). However, formal statistical analysis, performed using a
two-way analysis of covariance model in which age, gender and the
age-by-gender interactions were classification variables and body
weight was a continuous covariate, revealed no significant
differences between the AUC(0,12 h) and <em>C</em><sub>max</sub>
values for the young (both genders) and those for the elderly (both
genders) (<a href="/pmc/articles/PMC2015054/table/tbl4/" target=
"true" class="fig-table-link table figpopup" rid-figpopup="tbl4"
rid-ob="ob-tbl4" co-legend-rid=""><span>Table 4</span></a>). The
AUC(0,12 h) values for the elderly and the young differed by less
than 20% (469 ng ml<sup>−1</sup> h <em>vs</em> 555 ng
ml<sup>−1</sup> h; <em>P</em> &gt; 0.05; <a href=
"/pmc/articles/PMC2015054/table/tbl4/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl4" rid-ob=
"ob-tbl4" co-legend-rid=""><span>Table 4</span></a>). Similarly,
the <em>C</em><sub>max</sub> values for the elderly and the young
differed by less than 20% (70 ng ml<sup>−1</sup><em>vs</em> 84 ng
ml<sup>−1</sup>; <em>P</em> &gt; 0.05; <a href=
"/pmc/articles/PMC2015054/table/tbl4/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl4" rid-ob=
"ob-tbl4" co-legend-rid=""><span>Table 4</span></a>).</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl4"><a href="/pmc/articles/PMC2015054/table/tbl4/" target=
"table" rid-ob="ob-tbl4" rid-figpopup="tbl4" class=
"table img_link icnblk_img figpopup"><img alt="Table 4" title=
"Table 4" class="small-thumb" src=
"/pmc/articles/PMC2015054/table/tbl4/?report=thumb" src-large=
"/pmc/articles/PMC2015054/table/tbl4/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/table/tbl4/" target="table" rid-figpopup=
"tbl4" rid-ob="ob-tbl4">Table 4</a></div>
<!--caption a4-->
<div><span>Summary of steady-state pharmacokinetic parameters for
ziprasidone according to age.</span></div>
</div>
</div>
<p id="__p43" class="p">The analysis of covariance also revealed no
significant differences between the AUC(0,12 h) and
<em>C</em><sub>max</sub> values for the men (both age groups) and
those for the women (both age groups) (<a href=
"/pmc/articles/PMC2015054/table/tbl5/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl5" rid-ob=
"ob-tbl5" co-legend-rid=""><span>Table 5</span></a>).The AUC(0,12
h) values for the men and the women differed by less than 5% (498
ng ml<sup>−1</sup> h <em>vs</em> 522 ng ml<sup>−1</sup> h;
<em>P</em> &gt; 0.05; <a href=
"/pmc/articles/PMC2015054/table/tbl5/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl5" rid-ob=
"ob-tbl5" co-legend-rid=""><span>Table 5</span></a>). Similarly,
the <em>C</em><sub>max</sub> values for the men and the women
differed by less than 20% (71 ng ml<sup>−1</sup><em>vs</em> 82 ng
ml<sup>−1</sup>; <em>P</em> &gt; 0.05; <a href=
"/pmc/articles/PMC2015054/table/tbl5/" target="true" class=
"fig-table-link table figpopup" rid-figpopup="tbl5" rid-ob=
"ob-tbl5" co-legend-rid=""><span>Table 5</span></a>).</p>
<!--table ft1--><!--table-wrap mode=article t1-->
<div class="table-wrap iconblock ten_col whole_rhythm clearfix" id=
"tbl5"><a href="/pmc/articles/PMC2015054/table/tbl5/" target=
"table" rid-ob="ob-tbl5" rid-figpopup="tbl5" class=
"table img_link icnblk_img figpopup"><img alt="Table 5" title=
"Table 5" class="small-thumb" src=
"/pmc/articles/PMC2015054/table/tbl5/?report=thumb" src-large=
"/pmc/articles/PMC2015054/table/tbl5/?report=previmg" /></a>
<div class="icnblk_cntnt">
<div><a class="figpopup" href=
"/pmc/articles/PMC2015054/table/tbl5/" target="table" rid-figpopup=
"tbl5" rid-ob="ob-tbl5">Table 5</a></div>
<!--caption a4-->
<div><span>Summary of steady-state pharmacokinetic parameters for
ziprasidone according to gender.</span></div>
</div>
</div>
</div>
</div>
<div id="__sec16" class="tsec sec">
<h2 class="head no_bottom_margin" id="__sec16title">Discussion</h2>
<p id="__p46" class="p p-first">The objective of this study was to
evaluate the pharmacokinetics of oral ziprasidone at steady-state
in individuals of different ages and genders.</p>
<p id="__p47">All of the measured pharmacokinetic parameters varied
by considerably less than 50% among the subject groups. Indeed,
based on AUC(0,12 h), <em>C</em><sub>max</sub>,
<em>t</em><sub>max</sub> and λ<sub>z</sub> values at steady state,
there were no significant differences between the pharmacokinetics
of ziprasidone in the young men and those in the young women.
Overall exposure to ziprasidone, based upon AUC(0,12 h) and
<em>C</em><sub>max</sub> values in the elderly men was similar to
that in the young men. Although exposure in the elderly women
appeared to be greater than in the other groups, this relatively
high exposure appeared to be attributable to two outlying
individuals, who had both unusually high AUC(0,12 h) and
<em>C</em><sub>max</sub> values. There were no discernible reasons
why these two elderly women had high AUC(0,12 h) and
<em>C</em><sub>max</sub> values. Neither had unusually low body
weights and normalizing AUC(0,12 h) and <em>C</em><sub>max</sub>
values for body weight (70 kg) did not account for the small
difference in exposure. It is possible therefore that the
bioavailability of ziprasidone, administered orally with food, may
be greater in some elderly women than in other individuals.
However, the findings of this study do not demonstrate this
conclusively.</p>
<p id="__p48">Although the results showed that age and gender did
not influence substantially the pharmacokinetics of ziprasidone,
the relatively wide confidence intervals and small sample size do
not preclude this possibility. However, there is no clinical
evidence from patients with schizophrenia to suggest that there are
any clinical differences between men and women and young and
elderly patients treated with ziprasidone.</p>
<p id="__p49">In a similar study, the pharmacokinetics of the
antipsychotic agent, risperidone, were evaluated in eight healthy
young subjects and 12 healthy elderly subjects. Following the
administration of a single oral 1 mg dose, the AUC(0, ∞),
<em>t</em><sub>max</sub> and <em>t</em><sub>½,z</sub> values for
the active moiety of risperidone, 9-hydroxy-risperidone, were
significantly greater in the elderly subjects than in the young
subjects. Thus, although the pharmacokinetics of risperidone itself
in the elderly subjects were described as being comparable with
those in the young subjects, the authors recommended careful dose
titration of risperidone in the elderly [<a href="#b5" rid="b5"
class=" bibr popnode tag_hotlink tag_tooltip" id=
"__tag_311012641">5</a>].</p>
<p id="__p50">In another study, involving 12 patients aged 63–85
years with chronic schizophrenia, the steady-state pharmacokinetics
of the antipsychotic agent, quetiapine, were found to be influenced
by age. Following the oral administration of quetiapine in stepwise
incremental doses (25–250 mg per dose) the oral clearance of
quetiapine was approximately 50% lower in these elderly patients
compared with younger patients. The authors therefore stressed that
the clinically effective dose of quetiapine for elderly patients
may be 50% lower than that for younger patients [<a href="#b6" rid=
"b6" class=" bibr popnode">6</a>].</p>
<p id="__p51" class="p p-last">In conclusion, the pharmacokinetics
of ziprasidone do not appear to be influenced significantly by age
or gender. These findings suggest that there is no need for a
ziprasidone dosage adjustment for elderly subjects based on the
pharmacokinetics of the drug.</p>
</div>
<div id="__ref-listid865510" class="tsec sec">
<h2 class="head no_bottom_margin" id="__ref-listid865510title">
References</h2>
<div class="ref-list-sec sec" id="reference-list">
<div class="ref-cit-blk half_rhythm" id="b1">1. <span class=
"element-citation">Miceli JJ, Wilner KD, Hansen RA, et al. Single-
and multiple-dose pharmacokinetics under non-fasting conditions in
healthy male volunteers. <span><span class="ref-journal">Br J Clin
Pharmacol.</span> 2000;<span class="ref-vol">49</span>(Suppl.
1):5S–13S.</span> <span class="nowrap ref pmc">[<a class=
"int-reflink" href="/pmc/articles/PMC2015059/">PMC free
article</a>]</span> <span class="nowrap ref pubmed">[<a href=
"/pubmed/10771448" target="pmc_ext" ref=
"reftype=pubmed&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b2">2. <span class=
"element-citation">Howard HR, Lowe JA, Seeger TF, et al. 3 –
Benzisothiazolylpiperazine derivatives as potential atypical
antipsychotic agents. <span><span class="ref-journal">J Med
Chem.</span> 1996;<span class="ref-vol">39</span>:143–148.</span>
<span class="nowrap ref pubmed">[<a href="/pubmed/8568801" target=
"pmc_ext" ref=
"reftype=pubmed&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b3">3. <span class=
"element-citation">Metropolitan height and weight tables
<span><span class="ref-journal">Stat Bull Metrop Life Found.</span>
1983;<span class="ref-vol">64</span>:3–9.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/6623350" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b4">4. <span class=
"element-citation">Janiszewski JS, Fouda HG, Cole RO. Development
and validation of a high-sensitivity assay for an antipsychotic
agent, CP-88,059, with solid-phase extraction and narrow-bore
high-performance liquid chromatography. <span><span class=
"ref-journal">J Chromatogr.</span> 1995;<span class=
"ref-vol">668</span>:133–139.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/7550970" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b5">5. <span class=
"element-citation">Snoeck E, Van Peer A, Sack M. Influence of age,
renal and liver impairment on the pharmacokinetics or risperidone.
<span><span class="ref-journal">Psychopharmacology.</span>
1995;<span class="ref-vol">122</span>:223–229.</span> <span class=
"nowrap ref pubmed">[<a href="/pubmed/8748391" target="pmc_ext"
ref="reftype=pubmed&amp;article-id=2015054&amp;issue-id=151586&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div>
<div class="ref-cit-blk half_rhythm" id="b6">6. <span class=
"element-citation">Wong YWJ, Ewing BJ, Thrum PT. Multiple-dose
pharmacokinetics of ‘Seroquel’ (quetiapine) in elderly psychotic
patients. <span><span class="ref-journal">Schizophrenia Res.</span>
1997;<span class="ref-vol">24</span>:199–200.</span></span></div>
</div>
</div>
</div>
<!--post-content-->
<hr class="whole_rhythm no_bottom_margin" />
<div class="courtesy-note no_margin small">Articles from
<span class="acknowledgment-journal-title">British Journal of
Clinical Pharmacology</span> are provided here courtesy of
<strong>British Pharmacological Society</strong></div>
</div>
</div>
<!-- Book content --></div>
<div id="rightcolumn" class="four_col col last">
<!-- Custom content above discovery portlets -->
<div class="col6"></div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi=
"http://www.w3.org/2001/XMLSchema-instance">
<div class="try-button"><a href=
"/pmc/articles/PMC2015054/?report=reader"><img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/3838809"
alt="PubReader format: click here to try" /></a></div>
<div class="format-menu">
<h2>Formats:</h2>
<ul>
<li class="selected">Article</li>
<li style="list-style: none">|</li>
<li><a href=
"/pmc/articles/PMC2015054/?report=reader">PubReader</a></li>
<li style="list-style: none">|</li>
<li class="epub-link"><a href="/pmc/articles/PMC2015054/epub/">ePub
(beta)</a></li>
<li style="list-style: none">|</li>
<li><a href="/pmc/articles/PMC2015054/pdf/bcp0049-015S.pdf">PDF
(90K)</a></li>
<li style="list-style: none">|</li>
<li><a href="#" data-citationid="PMC2015054" class=
"citationexporter ctxp">Citation</a></li>
</ul>
</div>
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi=
"http://www.w3.org/2001/XMLSchema-instance" class="share-buttons">
<h2>Share</h2>
<ul>
<li class="facebook"><a href=
"https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015054%2F">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047626"
alt="Share on Facebook" /> Facebook</a></li>
<li class="twitter"><a href=
"https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015054%2F&amp;text=Single-%20and%20multiple-dose%20pharmacokinetics%20of%20ziprasidone%20in%20healthy%20young%20and%20elderly%20volunteers">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047627"
alt="Share on Twitter" /> Twitter</a></li>
<li class="gplus"><a href=
"https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2015054%2F">
<img src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/img/4047628"
alt="Share on Google Plus" /> Google+</a></li>
</ul>
</div>
<div id="ajax-portlets" data-pmid="10771449" data-aiid="2015054"
data-aid="2015054" data-iid="151586" data-domainid="279"
data-domain="brjclinpharm" data-accid="PMC2015054" data-md5=
"d000bec10b290792944868687619510e"></div>
<!-- Custom content below discovery portlets -->
<div class="col7"></div>
</div>
</div>
<!-- Custom content after all -->
<div class="col8"></div>
<div class="col9"></div>
<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js">
</script> <script>
<![CDATA[
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
]]>
</script>
<div id="body-link-poppers"></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<div class="breadcrumbs">You are here: <span id=
"breadcrumb_text"><a href="/guide/">NCBI</a> &gt; <a href=
"http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt;
<a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central
(PMC)</a></span></div>
<a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target=
"_blank" href=
"/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-04-01T09:54:11-04:00&amp;Host=ptpmc101">Write
to the Help Desk</a></div>
<div class="footer" id="footer">
<div class="subfooter"></div>
<script type="text/javascript" src=
"/portal/portal3rc.fcgi/static/js/preloaderWidget.js">
</script>
<div id="external-disclaimer" class="offscreen_noflow">External
link. Please review our <a href=
"http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div>
<div id="ncbifooter" class="contact_info">
<div id="footer-contents-right">
<div id="nlm_thumb_logo"><a href="http://www.nlm.nih.gov" title=
"NLM">NLM</a></div>
<div id="nih_thumb_logo"><a href="http://www.nih.gov" title=
"NIH">NIH</a></div>
<div id="hhs_thumb_logo"><a href="http://www.dhhs.gov" title=
"DHHS">DHHS</a></div>
<div id="usagov_thumb_logo"><a href="http://www.usa.gov" title=
"USA.gov">USA.gov</a></div>
</div>
<div id="footer-contents-left"><a href=
"/About/disclaimer.html">Copyright</a> | <a href=
"/About/disclaimer.html#disclaimer">Disclaimer</a> | <a href=
"http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a>
| <a href="/guide/browsers/">Browsers</a> | <a href=
"http://www.nlm.nih.gov/accessibility.html">Accessibility</a> |
<a href="/About/glance/contact_info.html">Contact</a>
<p class="address vcard"><span class="url"><a class=
"fn url newdomain" href="http://www.ncbi.nlm.nih.gov">National
Center for Biotechnology Information</a>,</span> <span class=
"org url"><a href="http://www.nlm.nih.gov/">U.S. National Library
of Medicine</a></span> <span class="adr"><span class=
"street-address">8600 Rockville Pike</span>, <span class=
"locality">Bethesda</span> <span class="region">MD</span>,
<span class="postal-code">20894</span> <span class=
"country-name">USA</span></span></p>
</div>
</div>
<script type="text/javascript" src=
"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1">
</script> <script type="text/javascript" src=
"/portal/portal3rc.fcgi/static/js/hfjs2.js">
</script></div>
</div>
</div>
<!--/.page--></div>
<!--/.wrap--></div>
<!-- /.twelve_col --></div>
<!-- /.grid -->
 <!-- BESelector tab -->
 <noscript><img alt="statistics" src=
"/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=brjclinpharm&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2015054/&amp;ncbi_app=pmc" />
</noscript> <!-- usually for JS scripts at page bottom -->
 <!--<component id="PageFixtures" label="styles"></component>-->
 
<!-- 8A1A2B6B6FE7D821_0102SID /projects/PMC/PMCViewer@4.35 ptpmc101 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->
 <script type="text/javascript" src=
"//static.pubmed.gov/portal/portal3rc.fcgi/4072591/js/3879255/3728312/3818874/3821238/4064716/4072593/4064449/3921943/4070217/4065628.js"
snapshot="pmc">
</script>
</body>
</html>
